Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding protein

Keyphrases

• Anti-CD3 50%
• Antitumor Activity 50%
• B-lymphoblastoid Cell Lines 50%
• Binding Protein 100%
• Cancer Immunotherapy 50%
• Cytotoxicity 50%
• Double Labeling 50%
• Drug-resistant Tumor 50%
• Human Cancer 50%
• Human Lymphocytes 100%
• Human Peripheral Blood Lymphocytes 100%
• Immunomodulatory Properties 50%
• Interleukin-2 50%
• Labeling Method 50%
• Lymphoblastoid Cells 100%
• Molecular Distribution 100%
• Molecular Mass 100%
• Monoclonal Antibody 100%
• Murine Lymphocytes 50%
• Natural Killer Cells 100%
• Non-reducing 50%
• Novel Antibodies 50%
• Peripheral T Cells 50%
• Reducing Conditions 50%
• Synergize 50%
• Tumor Cell Lines 50%

Immunology and Microbiology

• Antineoplastic Activity 50%
• B-Lymphoblastoid Cell Line 50%
• CD3 Antigen 50%
• Cytotoxicity 50%
• Immunotherapy 50%
• Interleukin 2 50%
• Intravenous Immunoglobulin 50%
• Lymphoblastoid Cell 100%
• Lymphocyte 100%
• Molecular Weight 100%
• Monoclonal Antibody 100%
• Natural Killer Cell 100%
• Peripheral Blood Lymphocyte 100%
• Protein Binding 100%
• T Cell 50%
• Tumor Cell Line 50%